This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Frank O. Becker, MD; Steven G. Economou, MD
Rush-Presbyterian-St. Luke's Medical Center Chicago

JAMA. 1975;231(13):1338-1339.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In a letter by Caswell and Maier (227:939, 1974) on the treatment of Graves disease, the authors conclude that the advantages of surgical treatment over radioactive iodine therapy and antithyroid drug treatment ensure that it will continue to be the standard by which other treatment methods are measured. They studied 72 patients with previous subtotal thyroidectomy for Graves disease and found a low incidence of postoperative hypothyroidism (10%) as well as a low incidence of recurrent hyperthyroidism (6%).¹ In support of this view, Griffiths et al,² studying 55 thyrotoxic patients following thyroidectomy, recently reported an 11% incidence of hypothyroidism and 3.5% incidence of recurrence. Successful treatment with radioactive iodine, on the other hand, is accompanied by an incidence of hypothyroidism of between 30% and 70% by 10 to 20 years of followup.³

It should be pointed out, however, that all studies are not in . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?